Psyence Biomedical Ltd
NASDAQ:PBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Psyence Biomedical Ltd
NASDAQ:PBM
|
CA |
|
Xinjiang Tianshan Cement Co Ltd
SZSE:000877
|
CN |
|
Netwealth Group Ltd
ASX:NWL
|
AU |
|
V
|
Vietjet Aviation JSC
VN:VJC
|
VN |
|
Rent.com.au Ltd
ASX:RNT
|
AU |
|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
US |
|
Z
|
Zhejiang Wanfeng Chemical Co Ltd
SSE:603172
|
CN |
|
D
|
Destiny Tech100 Inc
NYSE:DXYZ
|
US |
|
C
|
Cognyte Software Ltd
NASDAQ:CGNT
|
IL |
|
I
|
Indonesia Energy Corp Ltd
AMEX:INDO
|
ID |
|
A
|
Argonaut Resources N L
OTC:AGREF
|
AU |
|
A
|
Ahresty Corp
TSE:5852
|
JP |
|
Shinpoong Pharmaceutical Co Ltd
KRX:019170
|
KR |
|
O
|
Odas Elektrik Uretim Sanayi Ticaret AS
IST:ODAS.E
|
TR |
|
Swoop Holdings Ltd
ASX:SWP
|
AU |
|
Piquadro SpA
F:4LZ
|
IT |
Profitability Summary
Psyence Biomedical Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Psyence Biomedical Ltd
Margins Comparison
Psyence Biomedical Ltd Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| CA |
P
|
Psyence Biomedical Ltd
NASDAQ:PBM
|
2.5m USD |
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Psyence Biomedical Ltd Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CA |
P
|
Psyence Biomedical Ltd
NASDAQ:PBM
|
2.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
